A Study of Evorpacept (ALX148) in Patients With Advanced HER2+ Gastric Cancer (ASPEN-06)
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
No overall officials are registered on this study record. Site-level investigators, where published, appear with their sites below. Why? →
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
83 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Icon Cancer Centre Southport
Southport, Queensland, Australia
- Monash Medical Centre
Clayton, Victoria, Australia
- Universitair Ziekenhuis Antwerpen
Antwerp, Belgium
- Universitair Ziekenhuis Leuven - Campus Gasthuisberg
Leuven, Belgium
- Centre Hospitalier Universitaire de Liège
Liège, Belgium
- Fakultní Nemocnice Hradec Králové
Hradec Králové, Czechia
- Fakultní Nemocnice Olomouc
Olomouc, Czechia
- Vseobecna Fakultni Nemocnice V Praze
Prague, Czechia
- Centre Hospitalier Régional Et Universitaire de Besançon - Hôpital Jean-Minjoz
Besançon, France
- Centre Hospitalier Universitaire de Bordeaux
Bordeaux, France
- Hôpital Morvan
Brest, France
- Centre Léon Bérard
Lyon, France
- Hôpital Privé Jean Mermoz
Lyon, France
- Institut Paoli-Calmettes
Marseille, France
- Hôpital Saint-Antoine
Paris, France
- Hôpital Trousseau
Paris, France
- Hôpital Rangueil
Toulouse, France
- Azienda Ospedaliera Di Rilievo Nazionale E Di Alta Specializzazione Garibaldi
Catania, Italy
- Azienda Ospedaliero - Universitaria Careggi
Florence, Italy
- Fondazione Irccs - Istituto Nazionale Dei Tumori
Milan, Italy
- Policlinico Universitario Campus Bio-Medico
Roma, Italy
- Azienda Sanitaria Universitaria Friuli Centrale - P.O. Santa Maria Della Misericordia
Udine, Italy
- National Cancer Center Hospital East
Chiba, Japan
- Kyushu Cancer Center
Fukuoka, Japan
- Gifu University Hospital
Gifu, Japan
- Japanese Red Cross Kumamoto Hospital
Kumamoto, Japan
- University Hospital Kyoto Prefectural University of Medicine
Kyoto, Japan
- Nagasaki University Hospital
Nagasaki, Japan
- Kindai University Hospital
Osaka, Japan
- Osaka Prefectural Hospital Organization - Osaka International Cancer Institute
Osaka, Japan
- Saitama Cancer Center
Saitama, Japan
- Tohoku University Hospital
Sendai, Japan
- Shizuoka Cancer Center
Shizuoka, Japan
- Cancer Institute Hospital of Jfcr
Tokyo, Japan
- National Cancer Center Hospital
Tokyo, Japan
- Kanagawa Cancer Center
Yokohama, Japan
- Oita University Hospital - Hasama Campus
Ōita, Japan
- Icon Cancer Centre Farrer Park
Singapore, Singapore
- National Cancer Centre Singapore
Singapore, Singapore
- Dong-A University Hospital
Busan, South Korea
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 15 Jan 2022
- Primary completion
- 24 May 2024
- Completion
- 30 Jun 2026
- Last update posted
- 7 Aug 2025
- Registered enrollment
- 127
- Registry id
- NCT05002127
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.